Long-Term Weight Maintenance: By addressing both appetite control and muscle preservation, this combination makes it easier to maintain weight loss results over time
Buy Now & Unlock 360 Market Intelligence: Key Segmentation: GLP-1 analogues to hold 56.6% market share in 2024 By Drug Class: (Dipeptidyl Peptidase-4 (DPP-4) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Analogues) By Route of Administration: (Oral, Injectable) By Distribution Channel: (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Global Growth Regional Analysis: North America (U.S., Canada, Mexico) Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe) Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific) South America (Colombia, Brazil, Argentina, Rest of South America) Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa) Benefits of the Report: Chapter 1 - Market Overview: Kickstarts the report with a comprehensive snapshot of the Incretin-Based Drugs Market, summarizing key segments by region, product type, and application
Darrasse-Jze G, Bergot A-S, Durgeau A, Billiard F, Salomon BL, Cohen JL, et al
Effects of gender in amyotrophic lateral sclerosis
A randomized controlled trial of once-weekly semaglutide for limiting post-smoking cessation weight gain in smokers with overweight/obesity: Study protocol
A network meta-analysis examining 105 randomized controlled trials with 219,283 participants found no significant association between GLP-1 receptor agonists as a class and increased infection risk, including UTIs
